Lannett Petitions for Stay of Glycolax Withdrawal Order

Drug Industry Daily
A A
Lannett filed an emergency petition with the FDA requesting postponement of the agency’s withdrawal order for its ANDA for Glycolax pending a court ruling.

To View This Article:

Login

Subscribe To Drug Industry Daily